nodes	percent_of_prediction	percent_of_DWPC	metapath
Temsirolimus—Protein Kinase Inhibitors—Sunitinib—pancreatic cancer	0.482	1	CiPCiCtD
Temsirolimus—kidney cancer—pancreatic cancer	0.286	1	CtDrD
Temsirolimus—CYP3A7-CYP3A51P—Tamoxifen—pancreatic cancer	0.0108	0.0752	CbGbCtD
Temsirolimus—CYP3A7—Tamoxifen—pancreatic cancer	0.0108	0.0752	CbGbCtD
Temsirolimus—CYP3A7—Irinotecan—pancreatic cancer	0.00832	0.0577	CbGbCtD
Temsirolimus—CYP3A7-CYP3A51P—Irinotecan—pancreatic cancer	0.00832	0.0577	CbGbCtD
Temsirolimus—CYP3A5—Tamoxifen—pancreatic cancer	0.00812	0.0564	CbGbCtD
Temsirolimus—CYP3A5—Erlotinib—pancreatic cancer	0.00691	0.048	CbGbCtD
Temsirolimus—CYP3A5—Irinotecan—pancreatic cancer	0.00624	0.0433	CbGbCtD
Temsirolimus—CYP3A7—Docetaxel—pancreatic cancer	0.00609	0.0423	CbGbCtD
Temsirolimus—CYP3A7-CYP3A51P—Docetaxel—pancreatic cancer	0.00609	0.0423	CbGbCtD
Temsirolimus—CYP3A7—Sunitinib—pancreatic cancer	0.00607	0.0421	CbGbCtD
Temsirolimus—CYP3A7-CYP3A51P—Sunitinib—pancreatic cancer	0.00607	0.0421	CbGbCtD
Temsirolimus—ABCB1—Tamoxifen—pancreatic cancer	0.00529	0.0367	CbGbCtD
Temsirolimus—CYP2D6—Tamoxifen—pancreatic cancer	0.00498	0.0346	CbGbCtD
Temsirolimus—CYP3A5—Docetaxel—pancreatic cancer	0.00457	0.0317	CbGbCtD
Temsirolimus—ABCB1—Gemcitabine—pancreatic cancer	0.00456	0.0316	CbGbCtD
Temsirolimus—CYP3A5—Sunitinib—pancreatic cancer	0.00455	0.0316	CbGbCtD
Temsirolimus—ABCB1—Erlotinib—pancreatic cancer	0.0045	0.0312	CbGbCtD
Temsirolimus—CYP2D6—Erlotinib—pancreatic cancer	0.00424	0.0294	CbGbCtD
Temsirolimus—ABCB1—Irinotecan—pancreatic cancer	0.00406	0.0282	CbGbCtD
Temsirolimus—CYP3A4—Tamoxifen—pancreatic cancer	0.00317	0.022	CbGbCtD
Temsirolimus—ABCB1—Docetaxel—pancreatic cancer	0.00298	0.0207	CbGbCtD
Temsirolimus—ABCB1—Sunitinib—pancreatic cancer	0.00296	0.0206	CbGbCtD
Temsirolimus—CYP3A4—Erlotinib—pancreatic cancer	0.00269	0.0187	CbGbCtD
Temsirolimus—CYP3A4—Irinotecan—pancreatic cancer	0.00243	0.0169	CbGbCtD
Temsirolimus—ABCB1—Doxorubicin—pancreatic cancer	0.00222	0.0154	CbGbCtD
Temsirolimus—CYP2D6—Doxorubicin—pancreatic cancer	0.00209	0.0145	CbGbCtD
Temsirolimus—CYP3A4—Docetaxel—pancreatic cancer	0.00178	0.0124	CbGbCtD
Temsirolimus—CYP3A4—Sunitinib—pancreatic cancer	0.00177	0.0123	CbGbCtD
Temsirolimus—CYP3A4—Doxorubicin—pancreatic cancer	0.00133	0.00922	CbGbCtD
Temsirolimus—Fatigue—Gemcitabine—pancreatic cancer	3e-05	0.000482	CcSEcCtD
Temsirolimus—Gastritis—Epirubicin—pancreatic cancer	3e-05	0.000481	CcSEcCtD
Temsirolimus—Alanine aminotransferase increased—Epirubicin—pancreatic cancer	2.99e-05	0.00048	CcSEcCtD
Temsirolimus—Constipation—Gemcitabine—pancreatic cancer	2.97e-05	0.000478	CcSEcCtD
Temsirolimus—Pain—Gemcitabine—pancreatic cancer	2.97e-05	0.000478	CcSEcCtD
Temsirolimus—Nausea—Erlotinib—pancreatic cancer	2.97e-05	0.000478	CcSEcCtD
Temsirolimus—Decreased appetite—Fluorouracil—pancreatic cancer	2.97e-05	0.000477	CcSEcCtD
Temsirolimus—Diarrhoea—Sunitinib—pancreatic cancer	2.97e-05	0.000476	CcSEcCtD
Temsirolimus—Dysgeusia—Docetaxel—pancreatic cancer	2.96e-05	0.000476	CcSEcCtD
Temsirolimus—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	2.95e-05	0.000474	CcSEcCtD
Temsirolimus—Abdominal distension—Epirubicin—pancreatic cancer	2.95e-05	0.000473	CcSEcCtD
Temsirolimus—Blood creatinine increased—Doxorubicin—pancreatic cancer	2.94e-05	0.000472	CcSEcCtD
Temsirolimus—Influenza—Epirubicin—pancreatic cancer	2.93e-05	0.00047	CcSEcCtD
Temsirolimus—Dysphagia—Epirubicin—pancreatic cancer	2.93e-05	0.00047	CcSEcCtD
Temsirolimus—Back pain—Docetaxel—pancreatic cancer	2.92e-05	0.00047	CcSEcCtD
Temsirolimus—Pain—Fluorouracil—pancreatic cancer	2.92e-05	0.00047	CcSEcCtD
Temsirolimus—Gastrointestinal pain—Irinotecan—pancreatic cancer	2.92e-05	0.000469	CcSEcCtD
Temsirolimus—Dehydration—Doxorubicin—pancreatic cancer	2.91e-05	0.000468	CcSEcCtD
Temsirolimus—Dry skin—Doxorubicin—pancreatic cancer	2.87e-05	0.000461	CcSEcCtD
Temsirolimus—Dizziness—Sunitinib—pancreatic cancer	2.87e-05	0.00046	CcSEcCtD
Temsirolimus—Hypokalaemia—Doxorubicin—pancreatic cancer	2.85e-05	0.000458	CcSEcCtD
Temsirolimus—Abdominal pain—Irinotecan—pancreatic cancer	2.82e-05	0.000453	CcSEcCtD
Temsirolimus—Body temperature increased—Irinotecan—pancreatic cancer	2.82e-05	0.000453	CcSEcCtD
Temsirolimus—Aspartate aminotransferase increased—Doxorubicin—pancreatic cancer	2.82e-05	0.000453	CcSEcCtD
Temsirolimus—Bronchitis—Epirubicin—pancreatic cancer	2.81e-05	0.000452	CcSEcCtD
Temsirolimus—Anaemia—Docetaxel—pancreatic cancer	2.79e-05	0.000449	CcSEcCtD
Temsirolimus—Gastritis—Doxorubicin—pancreatic cancer	2.77e-05	0.000446	CcSEcCtD
Temsirolimus—Alanine aminotransferase increased—Doxorubicin—pancreatic cancer	2.76e-05	0.000444	CcSEcCtD
Temsirolimus—Vomiting—Sunitinib—pancreatic cancer	2.76e-05	0.000443	CcSEcCtD
Temsirolimus—Body temperature increased—Gemcitabine—pancreatic cancer	2.75e-05	0.000442	CcSEcCtD
Temsirolimus—Dysuria—Epirubicin—pancreatic cancer	2.74e-05	0.00044	CcSEcCtD
Temsirolimus—Neutropenia—Epirubicin—pancreatic cancer	2.74e-05	0.00044	CcSEcCtD
Temsirolimus—Rash—Sunitinib—pancreatic cancer	2.73e-05	0.000439	CcSEcCtD
Temsirolimus—Dermatitis—Sunitinib—pancreatic cancer	2.73e-05	0.000439	CcSEcCtD
Temsirolimus—Abdominal distension—Doxorubicin—pancreatic cancer	2.73e-05	0.000438	CcSEcCtD
Temsirolimus—Upper respiratory tract infection—Epirubicin—pancreatic cancer	2.72e-05	0.000437	CcSEcCtD
Temsirolimus—Headache—Sunitinib—pancreatic cancer	2.71e-05	0.000436	CcSEcCtD
Temsirolimus—Influenza—Doxorubicin—pancreatic cancer	2.71e-05	0.000435	CcSEcCtD
Temsirolimus—Dysphagia—Doxorubicin—pancreatic cancer	2.71e-05	0.000435	CcSEcCtD
Temsirolimus—Leukopenia—Docetaxel—pancreatic cancer	2.71e-05	0.000435	CcSEcCtD
Temsirolimus—Pollakiuria—Epirubicin—pancreatic cancer	2.7e-05	0.000434	CcSEcCtD
Temsirolimus—Body temperature increased—Fluorouracil—pancreatic cancer	2.7e-05	0.000434	CcSEcCtD
Temsirolimus—Weight decreased—Epirubicin—pancreatic cancer	2.65e-05	0.000425	CcSEcCtD
Temsirolimus—Hyperglycaemia—Epirubicin—pancreatic cancer	2.64e-05	0.000424	CcSEcCtD
Temsirolimus—Cough—Docetaxel—pancreatic cancer	2.64e-05	0.000424	CcSEcCtD
Temsirolimus—Hypersensitivity—Irinotecan—pancreatic cancer	2.63e-05	0.000423	CcSEcCtD
Temsirolimus—Pneumonia—Epirubicin—pancreatic cancer	2.62e-05	0.000422	CcSEcCtD
Temsirolimus—Convulsion—Docetaxel—pancreatic cancer	2.62e-05	0.000421	CcSEcCtD
Temsirolimus—Hypertension—Docetaxel—pancreatic cancer	2.61e-05	0.000419	CcSEcCtD
Temsirolimus—Infestation—Epirubicin—pancreatic cancer	2.61e-05	0.000419	CcSEcCtD
Temsirolimus—Infestation NOS—Epirubicin—pancreatic cancer	2.61e-05	0.000419	CcSEcCtD
Temsirolimus—Bronchitis—Doxorubicin—pancreatic cancer	2.6e-05	0.000418	CcSEcCtD
Temsirolimus—Stevens-Johnson syndrome—Epirubicin—pancreatic cancer	2.59e-05	0.000416	CcSEcCtD
Temsirolimus—Arthralgia—Docetaxel—pancreatic cancer	2.57e-05	0.000414	CcSEcCtD
Temsirolimus—Chest pain—Docetaxel—pancreatic cancer	2.57e-05	0.000414	CcSEcCtD
Temsirolimus—Myalgia—Docetaxel—pancreatic cancer	2.57e-05	0.000414	CcSEcCtD
Temsirolimus—Nausea—Sunitinib—pancreatic cancer	2.57e-05	0.000414	CcSEcCtD
Temsirolimus—Renal failure—Epirubicin—pancreatic cancer	2.57e-05	0.000412	CcSEcCtD
Temsirolimus—Asthenia—Irinotecan—pancreatic cancer	2.56e-05	0.000411	CcSEcCtD
Temsirolimus—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	2.56e-05	0.000411	CcSEcCtD
Temsirolimus—Stomatitis—Epirubicin—pancreatic cancer	2.54e-05	0.000409	CcSEcCtD
Temsirolimus—Urinary tract infection—Epirubicin—pancreatic cancer	2.54e-05	0.000408	CcSEcCtD
Temsirolimus—Conjunctivitis—Epirubicin—pancreatic cancer	2.54e-05	0.000408	CcSEcCtD
Temsirolimus—Dysuria—Doxorubicin—pancreatic cancer	2.53e-05	0.000407	CcSEcCtD
Temsirolimus—Neutropenia—Doxorubicin—pancreatic cancer	2.53e-05	0.000407	CcSEcCtD
Temsirolimus—Hypersensitivity—Fluorouracil—pancreatic cancer	2.52e-05	0.000405	CcSEcCtD
Temsirolimus—Upper respiratory tract infection—Doxorubicin—pancreatic cancer	2.52e-05	0.000404	CcSEcCtD
Temsirolimus—Pollakiuria—Doxorubicin—pancreatic cancer	2.5e-05	0.000402	CcSEcCtD
Temsirolimus—Asthenia—Gemcitabine—pancreatic cancer	2.49e-05	0.000401	CcSEcCtD
Temsirolimus—Haematuria—Epirubicin—pancreatic cancer	2.49e-05	0.0004	CcSEcCtD
Temsirolimus—Anaphylactic shock—Docetaxel—pancreatic cancer	2.47e-05	0.000396	CcSEcCtD
Temsirolimus—Oedema—Docetaxel—pancreatic cancer	2.47e-05	0.000396	CcSEcCtD
Temsirolimus—Epistaxis—Epirubicin—pancreatic cancer	2.46e-05	0.000395	CcSEcCtD
Temsirolimus—Pruritus—Gemcitabine—pancreatic cancer	2.46e-05	0.000395	CcSEcCtD
Temsirolimus—Infection—Docetaxel—pancreatic cancer	2.45e-05	0.000394	CcSEcCtD
Temsirolimus—Weight decreased—Doxorubicin—pancreatic cancer	2.45e-05	0.000394	CcSEcCtD
Temsirolimus—Sinusitis—Epirubicin—pancreatic cancer	2.45e-05	0.000393	CcSEcCtD
Temsirolimus—Hyperglycaemia—Doxorubicin—pancreatic cancer	2.44e-05	0.000392	CcSEcCtD
Temsirolimus—Diarrhoea—Irinotecan—pancreatic cancer	2.44e-05	0.000392	CcSEcCtD
Temsirolimus—Pneumonia—Doxorubicin—pancreatic cancer	2.43e-05	0.00039	CcSEcCtD
Temsirolimus—Nervous system disorder—Docetaxel—pancreatic cancer	2.42e-05	0.000389	CcSEcCtD
Temsirolimus—Pruritus—Fluorouracil—pancreatic cancer	2.42e-05	0.000389	CcSEcCtD
Temsirolimus—Thrombocytopenia—Docetaxel—pancreatic cancer	2.42e-05	0.000388	CcSEcCtD
Temsirolimus—Infestation NOS—Doxorubicin—pancreatic cancer	2.41e-05	0.000388	CcSEcCtD
Temsirolimus—Infestation—Doxorubicin—pancreatic cancer	2.41e-05	0.000388	CcSEcCtD
Temsirolimus—Skin disorder—Docetaxel—pancreatic cancer	2.4e-05	0.000385	CcSEcCtD
Temsirolimus—Stevens-Johnson syndrome—Doxorubicin—pancreatic cancer	2.39e-05	0.000385	CcSEcCtD
Temsirolimus—Diarrhoea—Gemcitabine—pancreatic cancer	2.38e-05	0.000382	CcSEcCtD
Temsirolimus—Renal failure—Doxorubicin—pancreatic cancer	2.37e-05	0.000381	CcSEcCtD
Temsirolimus—Dizziness—Irinotecan—pancreatic cancer	2.36e-05	0.000379	CcSEcCtD
Temsirolimus—Stomatitis—Doxorubicin—pancreatic cancer	2.35e-05	0.000378	CcSEcCtD
Temsirolimus—Anorexia—Docetaxel—pancreatic cancer	2.35e-05	0.000378	CcSEcCtD
Temsirolimus—Rhinitis—Epirubicin—pancreatic cancer	2.35e-05	0.000377	CcSEcCtD
Temsirolimus—Urinary tract infection—Doxorubicin—pancreatic cancer	2.35e-05	0.000377	CcSEcCtD
Temsirolimus—Conjunctivitis—Doxorubicin—pancreatic cancer	2.35e-05	0.000377	CcSEcCtD
Temsirolimus—Diarrhoea—Fluorouracil—pancreatic cancer	2.34e-05	0.000376	CcSEcCtD
Temsirolimus—Pharyngitis—Epirubicin—pancreatic cancer	2.33e-05	0.000374	CcSEcCtD
Temsirolimus—Urinary tract disorder—Epirubicin—pancreatic cancer	2.31e-05	0.000372	CcSEcCtD
Temsirolimus—Oedema peripheral—Epirubicin—pancreatic cancer	2.31e-05	0.000371	CcSEcCtD
Temsirolimus—Haematuria—Doxorubicin—pancreatic cancer	2.3e-05	0.00037	CcSEcCtD
Temsirolimus—Connective tissue disorder—Epirubicin—pancreatic cancer	2.3e-05	0.00037	CcSEcCtD
Temsirolimus—Urethral disorder—Epirubicin—pancreatic cancer	2.3e-05	0.000369	CcSEcCtD
Temsirolimus—Epistaxis—Doxorubicin—pancreatic cancer	2.28e-05	0.000366	CcSEcCtD
Temsirolimus—Vomiting—Irinotecan—pancreatic cancer	2.27e-05	0.000365	CcSEcCtD
Temsirolimus—Sinusitis—Doxorubicin—pancreatic cancer	2.27e-05	0.000364	CcSEcCtD
Temsirolimus—Dizziness—Fluorouracil—pancreatic cancer	2.26e-05	0.000363	CcSEcCtD
Temsirolimus—Rash—Irinotecan—pancreatic cancer	2.25e-05	0.000362	CcSEcCtD
Temsirolimus—Dermatitis—Irinotecan—pancreatic cancer	2.25e-05	0.000361	CcSEcCtD
Temsirolimus—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	2.25e-05	0.000361	CcSEcCtD
Temsirolimus—Headache—Irinotecan—pancreatic cancer	2.24e-05	0.000359	CcSEcCtD
Temsirolimus—Insomnia—Docetaxel—pancreatic cancer	2.23e-05	0.000359	CcSEcCtD
Temsirolimus—Erythema multiforme—Epirubicin—pancreatic cancer	2.22e-05	0.000356	CcSEcCtD
Temsirolimus—Vomiting—Gemcitabine—pancreatic cancer	2.21e-05	0.000355	CcSEcCtD
Temsirolimus—Dyspnoea—Docetaxel—pancreatic cancer	2.2e-05	0.000353	CcSEcCtD
Temsirolimus—Somnolence—Docetaxel—pancreatic cancer	2.19e-05	0.000352	CcSEcCtD
Temsirolimus—Rash—Gemcitabine—pancreatic cancer	2.19e-05	0.000352	CcSEcCtD
Temsirolimus—Dermatitis—Gemcitabine—pancreatic cancer	2.19e-05	0.000352	CcSEcCtD
Temsirolimus—Eye disorder—Epirubicin—pancreatic cancer	2.19e-05	0.000352	CcSEcCtD
Temsirolimus—Headache—Gemcitabine—pancreatic cancer	2.18e-05	0.00035	CcSEcCtD
Temsirolimus—Cardiac disorder—Epirubicin—pancreatic cancer	2.17e-05	0.000349	CcSEcCtD
Temsirolimus—Vomiting—Fluorouracil—pancreatic cancer	2.17e-05	0.000349	CcSEcCtD
Temsirolimus—Rhinitis—Doxorubicin—pancreatic cancer	2.17e-05	0.000349	CcSEcCtD
Temsirolimus—Rash—Fluorouracil—pancreatic cancer	2.16e-05	0.000346	CcSEcCtD
Temsirolimus—Dermatitis—Fluorouracil—pancreatic cancer	2.15e-05	0.000346	CcSEcCtD
Temsirolimus—Pharyngitis—Doxorubicin—pancreatic cancer	2.15e-05	0.000346	CcSEcCtD
Temsirolimus—Decreased appetite—Docetaxel—pancreatic cancer	2.15e-05	0.000345	CcSEcCtD
Temsirolimus—Headache—Fluorouracil—pancreatic cancer	2.14e-05	0.000344	CcSEcCtD
Temsirolimus—Urinary tract disorder—Doxorubicin—pancreatic cancer	2.14e-05	0.000344	CcSEcCtD
Temsirolimus—Oedema peripheral—Doxorubicin—pancreatic cancer	2.14e-05	0.000343	CcSEcCtD
Temsirolimus—Gastrointestinal disorder—Docetaxel—pancreatic cancer	2.13e-05	0.000342	CcSEcCtD
Temsirolimus—Connective tissue disorder—Doxorubicin—pancreatic cancer	2.13e-05	0.000342	CcSEcCtD
Temsirolimus—Fatigue—Docetaxel—pancreatic cancer	2.13e-05	0.000342	CcSEcCtD
Temsirolimus—Angiopathy—Epirubicin—pancreatic cancer	2.13e-05	0.000341	CcSEcCtD
Temsirolimus—Urethral disorder—Doxorubicin—pancreatic cancer	2.12e-05	0.000341	CcSEcCtD
Temsirolimus—Nausea—Irinotecan—pancreatic cancer	2.12e-05	0.000341	CcSEcCtD
Temsirolimus—Immune system disorder—Epirubicin—pancreatic cancer	2.12e-05	0.00034	CcSEcCtD
Temsirolimus—Mediastinal disorder—Epirubicin—pancreatic cancer	2.11e-05	0.000339	CcSEcCtD
Temsirolimus—Pain—Docetaxel—pancreatic cancer	2.11e-05	0.000339	CcSEcCtD
Temsirolimus—Constipation—Docetaxel—pancreatic cancer	2.11e-05	0.000339	CcSEcCtD
Temsirolimus—Chills—Epirubicin—pancreatic cancer	2.1e-05	0.000338	CcSEcCtD
Temsirolimus—Nausea—Gemcitabine—pancreatic cancer	2.07e-05	0.000332	CcSEcCtD
Temsirolimus—Mental disorder—Epirubicin—pancreatic cancer	2.05e-05	0.00033	CcSEcCtD
Temsirolimus—Erythema multiforme—Doxorubicin—pancreatic cancer	2.05e-05	0.000329	CcSEcCtD
Temsirolimus—Malnutrition—Epirubicin—pancreatic cancer	2.04e-05	0.000328	CcSEcCtD
Temsirolimus—Erythema—Epirubicin—pancreatic cancer	2.04e-05	0.000328	CcSEcCtD
Temsirolimus—Nausea—Fluorouracil—pancreatic cancer	2.03e-05	0.000326	CcSEcCtD
Temsirolimus—Eye disorder—Doxorubicin—pancreatic cancer	2.03e-05	0.000325	CcSEcCtD
Temsirolimus—Gastrointestinal pain—Docetaxel—pancreatic cancer	2.02e-05	0.000324	CcSEcCtD
Temsirolimus—Cardiac disorder—Doxorubicin—pancreatic cancer	2.01e-05	0.000323	CcSEcCtD
Temsirolimus—Dysgeusia—Epirubicin—pancreatic cancer	2e-05	0.000321	CcSEcCtD
Temsirolimus—Back pain—Epirubicin—pancreatic cancer	1.97e-05	0.000317	CcSEcCtD
Temsirolimus—Angiopathy—Doxorubicin—pancreatic cancer	1.97e-05	0.000316	CcSEcCtD
Temsirolimus—Immune system disorder—Doxorubicin—pancreatic cancer	1.96e-05	0.000315	CcSEcCtD
Temsirolimus—Mediastinal disorder—Doxorubicin—pancreatic cancer	1.95e-05	0.000314	CcSEcCtD
Temsirolimus—Abdominal pain—Docetaxel—pancreatic cancer	1.95e-05	0.000313	CcSEcCtD
Temsirolimus—Body temperature increased—Docetaxel—pancreatic cancer	1.95e-05	0.000313	CcSEcCtD
Temsirolimus—Chills—Doxorubicin—pancreatic cancer	1.94e-05	0.000312	CcSEcCtD
Temsirolimus—Mental disorder—Doxorubicin—pancreatic cancer	1.9e-05	0.000305	CcSEcCtD
Temsirolimus—Malnutrition—Doxorubicin—pancreatic cancer	1.89e-05	0.000303	CcSEcCtD
Temsirolimus—Erythema—Doxorubicin—pancreatic cancer	1.89e-05	0.000303	CcSEcCtD
Temsirolimus—Anaemia—Epirubicin—pancreatic cancer	1.88e-05	0.000303	CcSEcCtD
Temsirolimus—Dysgeusia—Doxorubicin—pancreatic cancer	1.85e-05	0.000297	CcSEcCtD
Temsirolimus—Leukopenia—Epirubicin—pancreatic cancer	1.83e-05	0.000293	CcSEcCtD
Temsirolimus—Back pain—Doxorubicin—pancreatic cancer	1.83e-05	0.000293	CcSEcCtD
Temsirolimus—Hypersensitivity—Docetaxel—pancreatic cancer	1.82e-05	0.000292	CcSEcCtD
Temsirolimus—Cough—Epirubicin—pancreatic cancer	1.78e-05	0.000286	CcSEcCtD
Temsirolimus—Asthenia—Docetaxel—pancreatic cancer	1.77e-05	0.000284	CcSEcCtD
Temsirolimus—Convulsion—Epirubicin—pancreatic cancer	1.77e-05	0.000284	CcSEcCtD
Temsirolimus—Hypertension—Epirubicin—pancreatic cancer	1.76e-05	0.000283	CcSEcCtD
Temsirolimus—Pruritus—Docetaxel—pancreatic cancer	1.75e-05	0.00028	CcSEcCtD
Temsirolimus—Anaemia—Doxorubicin—pancreatic cancer	1.74e-05	0.00028	CcSEcCtD
Temsirolimus—Chest pain—Epirubicin—pancreatic cancer	1.74e-05	0.000279	CcSEcCtD
Temsirolimus—Arthralgia—Epirubicin—pancreatic cancer	1.74e-05	0.000279	CcSEcCtD
Temsirolimus—Myalgia—Epirubicin—pancreatic cancer	1.74e-05	0.000279	CcSEcCtD
Temsirolimus—Anxiety—Epirubicin—pancreatic cancer	1.73e-05	0.000278	CcSEcCtD
Temsirolimus—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	1.72e-05	0.000277	CcSEcCtD
Temsirolimus—Leukopenia—Doxorubicin—pancreatic cancer	1.69e-05	0.000271	CcSEcCtD
Temsirolimus—Diarrhoea—Docetaxel—pancreatic cancer	1.69e-05	0.000271	CcSEcCtD
Temsirolimus—Anaphylactic shock—Epirubicin—pancreatic cancer	1.66e-05	0.000267	CcSEcCtD
Temsirolimus—Oedema—Epirubicin—pancreatic cancer	1.66e-05	0.000267	CcSEcCtD
Temsirolimus—Infection—Epirubicin—pancreatic cancer	1.65e-05	0.000266	CcSEcCtD
Temsirolimus—Cough—Doxorubicin—pancreatic cancer	1.65e-05	0.000265	CcSEcCtD
Temsirolimus—Convulsion—Doxorubicin—pancreatic cancer	1.63e-05	0.000263	CcSEcCtD
Temsirolimus—Nervous system disorder—Epirubicin—pancreatic cancer	1.63e-05	0.000262	CcSEcCtD
Temsirolimus—Dizziness—Docetaxel—pancreatic cancer	1.63e-05	0.000262	CcSEcCtD
Temsirolimus—Thrombocytopenia—Epirubicin—pancreatic cancer	1.63e-05	0.000262	CcSEcCtD
Temsirolimus—Hypertension—Doxorubicin—pancreatic cancer	1.63e-05	0.000262	CcSEcCtD
Temsirolimus—Skin disorder—Epirubicin—pancreatic cancer	1.62e-05	0.00026	CcSEcCtD
Temsirolimus—Arthralgia—Doxorubicin—pancreatic cancer	1.61e-05	0.000258	CcSEcCtD
Temsirolimus—Chest pain—Doxorubicin—pancreatic cancer	1.61e-05	0.000258	CcSEcCtD
Temsirolimus—Myalgia—Doxorubicin—pancreatic cancer	1.61e-05	0.000258	CcSEcCtD
Temsirolimus—Anxiety—Doxorubicin—pancreatic cancer	1.6e-05	0.000257	CcSEcCtD
Temsirolimus—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	1.6e-05	0.000256	CcSEcCtD
Temsirolimus—Anorexia—Epirubicin—pancreatic cancer	1.59e-05	0.000255	CcSEcCtD
Temsirolimus—Vomiting—Docetaxel—pancreatic cancer	1.57e-05	0.000252	CcSEcCtD
Temsirolimus—Rash—Docetaxel—pancreatic cancer	1.56e-05	0.00025	CcSEcCtD
Temsirolimus—Dermatitis—Docetaxel—pancreatic cancer	1.55e-05	0.00025	CcSEcCtD
Temsirolimus—Headache—Docetaxel—pancreatic cancer	1.55e-05	0.000248	CcSEcCtD
Temsirolimus—Oedema—Doxorubicin—pancreatic cancer	1.54e-05	0.000247	CcSEcCtD
Temsirolimus—Anaphylactic shock—Doxorubicin—pancreatic cancer	1.54e-05	0.000247	CcSEcCtD
Temsirolimus—Infection—Doxorubicin—pancreatic cancer	1.53e-05	0.000246	CcSEcCtD
Temsirolimus—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	1.52e-05	0.000244	CcSEcCtD
Temsirolimus—Nervous system disorder—Doxorubicin—pancreatic cancer	1.51e-05	0.000243	CcSEcCtD
Temsirolimus—Thrombocytopenia—Doxorubicin—pancreatic cancer	1.51e-05	0.000242	CcSEcCtD
Temsirolimus—Insomnia—Epirubicin—pancreatic cancer	1.51e-05	0.000242	CcSEcCtD
Temsirolimus—Skin disorder—Doxorubicin—pancreatic cancer	1.5e-05	0.00024	CcSEcCtD
Temsirolimus—Dyspnoea—Epirubicin—pancreatic cancer	1.48e-05	0.000238	CcSEcCtD
Temsirolimus—Somnolence—Epirubicin—pancreatic cancer	1.48e-05	0.000238	CcSEcCtD
Temsirolimus—Anorexia—Doxorubicin—pancreatic cancer	1.47e-05	0.000236	CcSEcCtD
Temsirolimus—Nausea—Docetaxel—pancreatic cancer	1.47e-05	0.000235	CcSEcCtD
Temsirolimus—Decreased appetite—Epirubicin—pancreatic cancer	1.45e-05	0.000232	CcSEcCtD
Temsirolimus—Gastrointestinal disorder—Epirubicin—pancreatic cancer	1.44e-05	0.000231	CcSEcCtD
Temsirolimus—Fatigue—Epirubicin—pancreatic cancer	1.43e-05	0.000231	CcSEcCtD
Temsirolimus—Constipation—Epirubicin—pancreatic cancer	1.42e-05	0.000229	CcSEcCtD
Temsirolimus—Pain—Epirubicin—pancreatic cancer	1.42e-05	0.000229	CcSEcCtD
Temsirolimus—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	1.4e-05	0.000225	CcSEcCtD
Temsirolimus—Insomnia—Doxorubicin—pancreatic cancer	1.39e-05	0.000224	CcSEcCtD
Temsirolimus—Dyspnoea—Doxorubicin—pancreatic cancer	1.37e-05	0.000221	CcSEcCtD
Temsirolimus—Somnolence—Doxorubicin—pancreatic cancer	1.37e-05	0.00022	CcSEcCtD
Temsirolimus—Gastrointestinal pain—Epirubicin—pancreatic cancer	1.36e-05	0.000219	CcSEcCtD
Temsirolimus—Decreased appetite—Doxorubicin—pancreatic cancer	1.34e-05	0.000215	CcSEcCtD
Temsirolimus—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	1.33e-05	0.000214	CcSEcCtD
Temsirolimus—Fatigue—Doxorubicin—pancreatic cancer	1.33e-05	0.000213	CcSEcCtD
Temsirolimus—Pain—Doxorubicin—pancreatic cancer	1.32e-05	0.000212	CcSEcCtD
Temsirolimus—Constipation—Doxorubicin—pancreatic cancer	1.32e-05	0.000212	CcSEcCtD
Temsirolimus—Body temperature increased—Epirubicin—pancreatic cancer	1.32e-05	0.000211	CcSEcCtD
Temsirolimus—Abdominal pain—Epirubicin—pancreatic cancer	1.32e-05	0.000211	CcSEcCtD
Temsirolimus—Gastrointestinal pain—Doxorubicin—pancreatic cancer	1.26e-05	0.000202	CcSEcCtD
Temsirolimus—Hypersensitivity—Epirubicin—pancreatic cancer	1.23e-05	0.000197	CcSEcCtD
Temsirolimus—Body temperature increased—Doxorubicin—pancreatic cancer	1.22e-05	0.000196	CcSEcCtD
Temsirolimus—Abdominal pain—Doxorubicin—pancreatic cancer	1.22e-05	0.000196	CcSEcCtD
Temsirolimus—Asthenia—Epirubicin—pancreatic cancer	1.19e-05	0.000192	CcSEcCtD
Temsirolimus—Pruritus—Epirubicin—pancreatic cancer	1.18e-05	0.000189	CcSEcCtD
Temsirolimus—Diarrhoea—Epirubicin—pancreatic cancer	1.14e-05	0.000183	CcSEcCtD
Temsirolimus—Hypersensitivity—Doxorubicin—pancreatic cancer	1.13e-05	0.000182	CcSEcCtD
Temsirolimus—Asthenia—Doxorubicin—pancreatic cancer	1.1e-05	0.000178	CcSEcCtD
Temsirolimus—Dizziness—Epirubicin—pancreatic cancer	1.1e-05	0.000177	CcSEcCtD
Temsirolimus—Pruritus—Doxorubicin—pancreatic cancer	1.09e-05	0.000175	CcSEcCtD
Temsirolimus—Vomiting—Epirubicin—pancreatic cancer	1.06e-05	0.00017	CcSEcCtD
Temsirolimus—Diarrhoea—Doxorubicin—pancreatic cancer	1.05e-05	0.000169	CcSEcCtD
Temsirolimus—Rash—Epirubicin—pancreatic cancer	1.05e-05	0.000169	CcSEcCtD
Temsirolimus—Dermatitis—Epirubicin—pancreatic cancer	1.05e-05	0.000168	CcSEcCtD
Temsirolimus—Headache—Epirubicin—pancreatic cancer	1.04e-05	0.000168	CcSEcCtD
Temsirolimus—Dizziness—Doxorubicin—pancreatic cancer	1.02e-05	0.000164	CcSEcCtD
Temsirolimus—Nausea—Epirubicin—pancreatic cancer	9.89e-06	0.000159	CcSEcCtD
Temsirolimus—Vomiting—Doxorubicin—pancreatic cancer	9.79e-06	0.000157	CcSEcCtD
Temsirolimus—Rash—Doxorubicin—pancreatic cancer	9.71e-06	0.000156	CcSEcCtD
Temsirolimus—Dermatitis—Doxorubicin—pancreatic cancer	9.7e-06	0.000156	CcSEcCtD
Temsirolimus—Headache—Doxorubicin—pancreatic cancer	9.65e-06	0.000155	CcSEcCtD
Temsirolimus—Nausea—Doxorubicin—pancreatic cancer	9.15e-06	0.000147	CcSEcCtD
Temsirolimus—MTOR—Signaling by NGF—PIK3CA—pancreatic cancer	6.79e-06	0.000258	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—NOTCH4—pancreatic cancer	6.76e-06	0.000257	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—IAPP—pancreatic cancer	6.72e-06	0.000255	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—SLC2A2—pancreatic cancer	6.69e-06	0.000254	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—TERT—pancreatic cancer	6.59e-06	0.00025	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—pancreatic cancer	6.56e-06	0.000249	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—PTHLH—pancreatic cancer	6.45e-06	0.000245	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—PTCH1—pancreatic cancer	6.45e-06	0.000245	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—TYMP—pancreatic cancer	6.42e-06	0.000244	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—PRSS1—pancreatic cancer	6.39e-06	0.000243	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—PIK3CB—pancreatic cancer	6.35e-06	0.000241	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—HIF1A—pancreatic cancer	6.3e-06	0.000239	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—TSC2—pancreatic cancer	6.29e-06	0.000239	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by NGF—HRAS—pancreatic cancer	6.28e-06	0.000239	CbGpPWpGaD
Temsirolimus—MTOR—Disease—SMAD4—pancreatic cancer	6.18e-06	0.000235	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—APOE—pancreatic cancer	6.15e-06	0.000234	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—PIK3CB—pancreatic cancer	6.1e-06	0.000232	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—pancreatic cancer	6.09e-06	0.000231	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—PIK3CB—pancreatic cancer	6.07e-06	0.000231	CbGpPWpGaD
Temsirolimus—MTOR—Disease—HES1—pancreatic cancer	6.04e-06	0.000229	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—PRSS1—pancreatic cancer	6.03e-06	0.000229	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—KDR—pancreatic cancer	6.03e-06	0.000229	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—PTGS2—pancreatic cancer	6.02e-06	0.000229	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—pancreatic cancer	5.93e-06	0.000225	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—SST—pancreatic cancer	5.9e-06	0.000224	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—pancreatic cancer	5.87e-06	0.000223	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—JAG1—pancreatic cancer	5.77e-06	0.000219	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—NOTCH3—pancreatic cancer	5.75e-06	0.000218	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—NFKBIA—pancreatic cancer	5.73e-06	0.000218	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—pancreatic cancer	5.72e-06	0.000217	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—NOTCH1—pancreatic cancer	5.68e-06	0.000216	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—CTNNB1—pancreatic cancer	5.63e-06	0.000214	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—PIK3CG—pancreatic cancer	5.55e-06	0.000211	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by NGF—AKT1—pancreatic cancer	5.55e-06	0.000211	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—ARG2—pancreatic cancer	5.54e-06	0.000211	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—BCL2L1—pancreatic cancer	5.5e-06	0.000209	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—PTEN—pancreatic cancer	5.49e-06	0.000209	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—EGF—pancreatic cancer	5.49e-06	0.000208	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—TSC2—pancreatic cancer	5.47e-06	0.000208	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—CNR1—pancreatic cancer	5.45e-06	0.000207	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—CTNNB1—pancreatic cancer	5.39e-06	0.000205	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—pancreatic cancer	5.31e-06	0.000202	CbGpPWpGaD
Temsirolimus—MTOR—Disease—TERT—pancreatic cancer	5.29e-06	0.000201	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—PTEN—pancreatic cancer	5.27e-06	0.0002	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—GCG—pancreatic cancer	5.26e-06	0.0002	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—PTEN—pancreatic cancer	5.25e-06	0.000199	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—ARG2—pancreatic cancer	5.22e-06	0.000198	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—CD44—pancreatic cancer	5.18e-06	0.000197	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—GLP1R—pancreatic cancer	5.18e-06	0.000197	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—pancreatic cancer	5.17e-06	0.000196	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—DPYD—pancreatic cancer	5.09e-06	0.000193	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—SRC—pancreatic cancer	5.09e-06	0.000193	CbGpPWpGaD
Temsirolimus—MTOR—Disease—HIF1A—pancreatic cancer	5.06e-06	0.000192	CbGpPWpGaD
Temsirolimus—MTOR—Disease—TSC2—pancreatic cancer	5.05e-06	0.000192	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—AGTR1—pancreatic cancer	5.02e-06	0.000191	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—NFKBIA—pancreatic cancer	4.99e-06	0.000189	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—GCG—pancreatic cancer	4.96e-06	0.000189	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—STK11—pancreatic cancer	4.94e-06	0.000188	CbGpPWpGaD
Temsirolimus—MTOR—Disease—APOE—pancreatic cancer	4.94e-06	0.000188	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—NRAS—pancreatic cancer	4.9e-06	0.000186	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—SRC—pancreatic cancer	4.89e-06	0.000186	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—PIK3CD—pancreatic cancer	4.88e-06	0.000185	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—SRC—pancreatic cancer	4.87e-06	0.000185	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—TYMP—pancreatic cancer	4.85e-06	0.000184	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—SLC2A2—pancreatic cancer	4.83e-06	0.000184	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—EGF—pancreatic cancer	4.77e-06	0.000181	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—pancreatic cancer	4.76e-06	0.000181	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—pancreatic cancer	4.74e-06	0.00018	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—NRAS—pancreatic cancer	4.7e-06	0.000179	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—STAT3—pancreatic cancer	4.69e-06	0.000178	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—NRAS—pancreatic cancer	4.68e-06	0.000178	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—STK11—pancreatic cancer	4.67e-06	0.000177	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—pancreatic cancer	4.65e-06	0.000177	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—TYMP—pancreatic cancer	4.57e-06	0.000173	CbGpPWpGaD
Temsirolimus—MTOR—Disease—NOTCH1—pancreatic cancer	4.56e-06	0.000173	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—EGFR—pancreatic cancer	4.46e-06	0.000169	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—CDH1—pancreatic cancer	4.44e-06	0.000169	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—pancreatic cancer	4.43e-06	0.000168	CbGpPWpGaD
Temsirolimus—MTOR—Disease—EGF—pancreatic cancer	4.41e-06	0.000167	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—pancreatic cancer	4.39e-06	0.000167	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—MYC—pancreatic cancer	4.36e-06	0.000166	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—TGFB1—pancreatic cancer	4.35e-06	0.000165	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—SMAD4—pancreatic cancer	4.33e-06	0.000165	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—EGFR—pancreatic cancer	4.28e-06	0.000163	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—EGFR—pancreatic cancer	4.27e-06	0.000162	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—PIK3CB—pancreatic cancer	4.25e-06	0.000162	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—PIK3CD—pancreatic cancer	4.24e-06	0.000161	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—HES1—pancreatic cancer	4.23e-06	0.000161	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—KRAS—pancreatic cancer	4.22e-06	0.00016	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—CXCL8—pancreatic cancer	4.09e-06	0.000155	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—KRAS—pancreatic cancer	4.05e-06	0.000154	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—pancreatic cancer	4.04e-06	0.000153	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—KRAS—pancreatic cancer	4.03e-06	0.000153	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—TYMS—pancreatic cancer	4.01e-06	0.000153	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—PRSS1—pancreatic cancer	3.94e-06	0.00015	CbGpPWpGaD
Temsirolimus—MTOR—Disease—PIK3CD—pancreatic cancer	3.92e-06	0.000149	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—CASP3—pancreatic cancer	3.91e-06	0.000149	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—GLP1R—pancreatic cancer	3.91e-06	0.000148	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—pancreatic cancer	3.91e-06	0.000148	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—PIK3CA—pancreatic cancer	3.87e-06	0.000147	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—DPYD—pancreatic cancer	3.84e-06	0.000146	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—CCND1—pancreatic cancer	3.81e-06	0.000145	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—CTNNB1—pancreatic cancer	3.77e-06	0.000143	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—CD44—pancreatic cancer	3.74e-06	0.000142	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—PIK3CA—pancreatic cancer	3.72e-06	0.000141	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—TERT—pancreatic cancer	3.71e-06	0.000141	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—PIK3CA—pancreatic cancer	3.7e-06	0.000141	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—PIK3CB—pancreatic cancer	3.7e-06	0.000141	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—MMP9—pancreatic cancer	3.7e-06	0.00014	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—GLP1R—pancreatic cancer	3.68e-06	0.00014	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—PTEN—pancreatic cancer	3.68e-06	0.00014	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—SLC2A2—pancreatic cancer	3.65e-06	0.000139	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—DPYD—pancreatic cancer	3.62e-06	0.000138	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—GCG—pancreatic cancer	3.59e-06	0.000136	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—HRAS—pancreatic cancer	3.58e-06	0.000136	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—HIF1A—pancreatic cancer	3.54e-06	0.000135	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—TSC2—pancreatic cancer	3.53e-06	0.000134	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—APOE—pancreatic cancer	3.46e-06	0.000131	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—HRAS—pancreatic cancer	3.44e-06	0.000131	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—SLC2A2—pancreatic cancer	3.44e-06	0.000131	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—HRAS—pancreatic cancer	3.43e-06	0.00013	CbGpPWpGaD
Temsirolimus—MTOR—Disease—PIK3CB—pancreatic cancer	3.42e-06	0.00013	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—ARG2—pancreatic cancer	3.42e-06	0.00013	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—SRC—pancreatic cancer	3.41e-06	0.000129	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—KDR—pancreatic cancer	3.39e-06	0.000129	CbGpPWpGaD
Temsirolimus—MTOR—Disease—PTGS2—pancreatic cancer	3.38e-06	0.000129	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—STK11—pancreatic cancer	3.37e-06	0.000128	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—VEGFA—pancreatic cancer	3.32e-06	0.000126	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—pancreatic cancer	3.3e-06	0.000125	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—STAT3—pancreatic cancer	3.29e-06	0.000125	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—CTNNB1—pancreatic cancer	3.28e-06	0.000125	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—NRAS—pancreatic cancer	3.28e-06	0.000125	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—APOE—pancreatic cancer	3.27e-06	0.000124	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—NFKBIA—pancreatic cancer	3.22e-06	0.000122	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—PTEN—pancreatic cancer	3.2e-06	0.000121	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—NOTCH1—pancreatic cancer	3.19e-06	0.000121	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—AKT1—pancreatic cancer	3.16e-06	0.00012	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—PIK3CG—pancreatic cancer	3.12e-06	0.000119	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—EGF—pancreatic cancer	3.09e-06	0.000117	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—MYC—pancreatic cancer	3.05e-06	0.000116	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—TGFB1—pancreatic cancer	3.05e-06	0.000116	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—AKT1—pancreatic cancer	3.04e-06	0.000115	CbGpPWpGaD
Temsirolimus—MTOR—Disease—CTNNB1—pancreatic cancer	3.03e-06	0.000115	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—AKT1—pancreatic cancer	3.02e-06	0.000115	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—EGFR—pancreatic cancer	2.99e-06	0.000113	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—TYMP—pancreatic cancer	2.99e-06	0.000113	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—SRC—pancreatic cancer	2.96e-06	0.000113	CbGpPWpGaD
Temsirolimus—MTOR—Disease—PTEN—pancreatic cancer	2.95e-06	0.000112	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—PIK3CG—pancreatic cancer	2.95e-06	0.000112	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—TYMS—pancreatic cancer	2.9e-06	0.00011	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—STAT3—pancreatic cancer	2.86e-06	0.000109	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—NRAS—pancreatic cancer	2.85e-06	0.000108	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—PPARG—pancreatic cancer	2.84e-06	0.000108	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—CD44—pancreatic cancer	2.82e-06	0.000107	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—KRAS—pancreatic cancer	2.82e-06	0.000107	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—PIK3CD—pancreatic cancer	2.74e-06	0.000104	CbGpPWpGaD
Temsirolimus—MTOR—Disease—SRC—pancreatic cancer	2.74e-06	0.000104	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—GCG—pancreatic cancer	2.71e-06	0.000103	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—CD44—pancreatic cancer	2.66e-06	0.000101	CbGpPWpGaD
Temsirolimus—MTOR—Disease—STAT3—pancreatic cancer	2.64e-06	0.0001	CbGpPWpGaD
Temsirolimus—MTOR—Disease—NRAS—pancreatic cancer	2.63e-06	0.0001	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—EGFR—pancreatic cancer	2.6e-06	9.87e-05	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—PIK3CA—pancreatic cancer	2.59e-06	9.85e-05	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—PIK3CD—pancreatic cancer	2.59e-06	9.84e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—GCG—pancreatic cancer	2.55e-06	9.69e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—STK11—pancreatic cancer	2.55e-06	9.67e-05	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—TP53—pancreatic cancer	2.51e-06	9.53e-05	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—KRAS—pancreatic cancer	2.46e-06	9.33e-05	CbGpPWpGaD
Temsirolimus—MTOR—Disease—MYC—pancreatic cancer	2.45e-06	9.32e-05	CbGpPWpGaD
Temsirolimus—MTOR—Disease—TGFB1—pancreatic cancer	2.45e-06	9.3e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—GLP1R—pancreatic cancer	2.41e-06	9.14e-05	CbGpPWpGaD
Temsirolimus—MTOR—Disease—EGFR—pancreatic cancer	2.4e-06	9.11e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—STK11—pancreatic cancer	2.4e-06	9.11e-05	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—HRAS—pancreatic cancer	2.4e-06	9.11e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—PIK3CB—pancreatic cancer	2.39e-06	9.09e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—DPYD—pancreatic cancer	2.37e-06	8.99e-05	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—APOE—pancreatic cancer	2.36e-06	8.97e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—CXCL8—pancreatic cancer	2.3e-06	8.73e-05	CbGpPWpGaD
Temsirolimus—MTOR—Disease—KRAS—pancreatic cancer	2.27e-06	8.61e-05	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—PIK3CB—pancreatic cancer	2.26e-06	8.58e-05	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—PIK3CA—pancreatic cancer	2.26e-06	8.57e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—SLC2A2—pancreatic cancer	2.25e-06	8.54e-05	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—PTGS2—pancreatic cancer	2.24e-06	8.5e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—CASP3—pancreatic cancer	2.2e-06	8.36e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—TYMS—pancreatic cancer	2.19e-06	8.32e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—CCND1—pancreatic cancer	2.14e-06	8.14e-05	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—PIK3CG—pancreatic cancer	2.13e-06	8.09e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—CTNNB1—pancreatic cancer	2.12e-06	8.06e-05	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—AKT1—pancreatic cancer	2.12e-06	8.05e-05	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—HRAS—pancreatic cancer	2.09e-06	7.93e-05	CbGpPWpGaD
Temsirolimus—MTOR—Disease—PIK3CA—pancreatic cancer	2.08e-06	7.91e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—MMP9—pancreatic cancer	2.08e-06	7.9e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—PTEN—pancreatic cancer	2.07e-06	7.85e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—TYMS—pancreatic cancer	2.06e-06	7.84e-05	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—PPARG—pancreatic cancer	2.06e-06	7.81e-05	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—PTEN—pancreatic cancer	1.95e-06	7.41e-05	CbGpPWpGaD
Temsirolimus—MTOR—Disease—HRAS—pancreatic cancer	1.93e-06	7.32e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—SRC—pancreatic cancer	1.92e-06	7.28e-05	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—PIK3CD—pancreatic cancer	1.87e-06	7.11e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—VEGFA—pancreatic cancer	1.87e-06	7.09e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—STAT3—pancreatic cancer	1.85e-06	7.02e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—NRAS—pancreatic cancer	1.84e-06	7.01e-05	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—AKT1—pancreatic cancer	1.84e-06	7e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—APOE—pancreatic cancer	1.78e-06	6.77e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—CD44—pancreatic cancer	1.74e-06	6.61e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—MYC—pancreatic cancer	1.72e-06	6.53e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—TGFB1—pancreatic cancer	1.71e-06	6.51e-05	CbGpPWpGaD
Temsirolimus—MTOR—Disease—AKT1—pancreatic cancer	1.7e-06	6.46e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—EGFR—pancreatic cancer	1.68e-06	6.38e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—APOE—pancreatic cancer	1.68e-06	6.38e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—GCG—pancreatic cancer	1.67e-06	6.34e-05	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—PIK3CB—pancreatic cancer	1.63e-06	6.2e-05	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—PTGS2—pancreatic cancer	1.62e-06	6.14e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—PIK3CG—pancreatic cancer	1.61e-06	6.11e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—KRAS—pancreatic cancer	1.59e-06	6.03e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—STK11—pancreatic cancer	1.57e-06	5.96e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—PPARG—pancreatic cancer	1.55e-06	5.89e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—PIK3CG—pancreatic cancer	1.51e-06	5.75e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—PPARG—pancreatic cancer	1.46e-06	5.55e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—PIK3CA—pancreatic cancer	1.46e-06	5.54e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—PIK3CD—pancreatic cancer	1.41e-06	5.37e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—TP53—pancreatic cancer	1.41e-06	5.36e-05	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—PTEN—pancreatic cancer	1.41e-06	5.36e-05	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—PIK3CA—pancreatic cancer	1.38e-06	5.23e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—TYMS—pancreatic cancer	1.35e-06	5.13e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—HRAS—pancreatic cancer	1.35e-06	5.13e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—PIK3CD—pancreatic cancer	1.33e-06	5.06e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—PIK3CB—pancreatic cancer	1.23e-06	4.68e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—PTGS2—pancreatic cancer	1.22e-06	4.64e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—AKT1—pancreatic cancer	1.19e-06	4.53e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—PIK3CB—pancreatic cancer	1.16e-06	4.41e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—PTGS2—pancreatic cancer	1.15e-06	4.37e-05	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—AKT1—pancreatic cancer	1.12e-06	4.27e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—APOE—pancreatic cancer	1.1e-06	4.17e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—PTEN—pancreatic cancer	1.06e-06	4.04e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—PTEN—pancreatic cancer	1e-06	3.81e-05	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—PIK3CA—pancreatic cancer	9.95e-07	3.78e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—PIK3CG—pancreatic cancer	9.9e-07	3.76e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—PPARG—pancreatic cancer	9.56e-07	3.63e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—PIK3CD—pancreatic cancer	8.71e-07	3.31e-05	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—AKT1—pancreatic cancer	8.13e-07	3.09e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—PIK3CB—pancreatic cancer	7.59e-07	2.88e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—PTGS2—pancreatic cancer	7.52e-07	2.86e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—PIK3CA—pancreatic cancer	7.51e-07	2.85e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—PIK3CA—pancreatic cancer	7.08e-07	2.69e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—PTEN—pancreatic cancer	6.56e-07	2.49e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—AKT1—pancreatic cancer	6.13e-07	2.33e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—AKT1—pancreatic cancer	5.78e-07	2.2e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—PIK3CA—pancreatic cancer	4.63e-07	1.76e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—AKT1—pancreatic cancer	3.78e-07	1.44e-05	CbGpPWpGaD
